BTK and diffuse large B-cell lymphoma: To this aim, we probed the BTK-expressing diffuse large B-cell lymphoma (DLBCL) cell line TMD867 with DDa-1 at various concentrations and could confirm BTK degradation with sub-μM potency (Fig. 5d).